021 - "Options" with Karandeep Singh Badwal

Let's Combinate · 23 Feb 2022 · 1h 03m

What this episode covers

Karandeep Singh Badwal, a QA/RA consultant and host of The MedTech Podcast, explains how defining 'intended use' determines whether a product is a regulated medical device or unregulated software, a critical distinction for startups. He details the specific regulatory challenges of Software as a Medical Device (SaMD), including cybersecurity, GDPR compliance, and the impact of the EU MDR on software classification. Badwal also discusses the strategic advantages for UK software companies post-Brexit, where they can still self-certify as Class 1 devices while EU counterparts face stricter notified body audits.

Mentioned

Products
Proximie
Also
The MedTech Podcast, Eudamed, MHRA, FDA, MDR, MDD, ISO 13485, GDPR, Robert Green, 48 Laws of Power, The 50th Law, Daily Laws

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 46m

    Everything you Need to Know about SaMD from an FDA Perspective

    David Pudwill, a former FDA official known as 'Mr. Regulatory', joins host Jon Speer to explain the regulatory landscape for Software as a Medical Device (SaMD). They define SaMD versus Software in a Medical Device (SiMD), discuss risk categorization based on intended use, and outline the FDA's Software Pre-certification Pilot Program. Pudwill advises developers to engage in early pre-submissions (Q-Subs) and utilize FDA guidance documents to navigate the path to clearance.

  • Global Medical Device Podcast · 51m

    Digitizing your SaMD Testing

    Rahul Kallampunathil, Vice President of Arbour Group’s Digital Compliance practice, explains the regulatory and testing requirements for Software as a Medical Device (SaMD). He distinguishes SaMD from Software in a Medical Device (SiMD) and Medical Device Data Systems (MDDS), noting that SaMD requires a full regulatory pathway while MDDS is often Class I. Kallampunathil advocates for adopting agile and DevOps methodologies with automated testing to manage the rapid iteration cycles of SaMD, contrasting this with traditional Computer Software Validation (CSV) in favor of Computer Software Assurance (CSA). He emphasizes that quality management systems must be established before product design and that post-market surveillance, including cybersecurity and platform compatibility, is critical for SaMD success.

  • Global Medical Device Podcast · 32m

    Understanding the Value of a Medical Device Guru

    Tom Rish, Senior Medical Device Guru and manager of the Guru team at Greenlight Guru, explains how the company provides mentorship and regulatory support to medical device companies beyond its QMS software. He discusses the 'Guru Edge,' emphasizing a phased 'build as you go' approach to quality systems to help startups launch products and pass audits without being overwhelmed by paperwork. Rish highlights industry trends including the rise of wearables, software as a medical device (SaMD), and the impact of EU MDR and IVDR regulations on In Vitro Diagnostics (IVD).

  • Global Medical Device Podcast · 40m

    The Future of Cybersecurity

    Chris Gates, Director of Product Security at Velentium and author of 'Medical Device Cybersecurity for Engineers and Manufacturers', discusses the evolving landscape of software as a medical device (SaMD) security. He critiques the FDA's recent draft guidance for lacking harmonization with global standards like ISO and EU MDR, arguing that it imposes excessive burdens without clear, workable requirements. Gates emphasizes the critical need for machine-readable Software Bill of Materials (SBOMs) and Vulnerability Exposure (VEX) documents to help Health Delivery Organizations (HDOs) manage risks effectively. He advocates for integrating cybersecurity into the core development process, using tools like MedCrip and Heimdal, to streamline regulatory approval and create a competitive advantage for manufacturers.

  • Global Medical Device Podcast · 44m

    #426: Software as a Medical Device: Securing Your Digital Future

    Jose Bohorquez and Mohamad Foustok from CyberMed explain that Software as a Medical Device (SaMD) must be treated as a medical device from inception, integrating security into the architecture rather than treating it as an afterthought. They highlight the 2023 FDA guidance shift, which raised the regulatory bar for all devices with software functions, regardless of connectivity, and discuss the 'zero trust' principle and 'reasonable assurance of cybersecurity.' The guests warn that skipping architectural planning leads to costly redesigns and legal risks, citing the recent $9.8 million DOJ settlement with Illumina as a cautionary tale for legacy devices.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.